热门资讯> 正文
ARCA Biopharma Closes Merger With Oruka Therapeutics
2024-08-30 06:03
06:03 PM EDT, 08/29/2024 (MT Newswires) -- ARCA Biopharma (ABIO) said late Thursday that it completed its merger with Oruka Therapeutics following a stockholder approval at a special meeting on Aug. 22.
In addition, the combined company will implement a reverse stock split at a ratio of 1-for-12 shares, the company said.
The combined company will operate under Oruka Therapeutics, with shares to begin trading on a post-reverse split on Nasdaq under the ORKA ticker symbol from Sept. 3.
Price: 2.5500, Change: +0.05, Percent Change: +2.00
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
